BioArctic AB (publ) (BIOA-B.ST)

SEK 170.0

(-0.93%)

Eps Summary of BioArctic AB (publ)

  • BioArctic AB (publ)'s latest annual eps in 2023 was 2.60 SEK , up 2100.0% from previous year.
  • BioArctic AB (publ)'s latest quarterly eps in 2024 Q2 was -0.77 SEK , down -18.46% from previous quarter.
  • BioArctic AB (publ) reported an annual eps of -0.13 SEK in 2022, up 90.44% from previous year.
  • BioArctic AB (publ) reported an annual eps of -1.36 SEK in 2021, down -74.36% from previous year.
  • BioArctic AB (publ) reported a quarterly eps of -0.65 SEK for 2024 Q1, up 34.34% from previous quarter.
  • BioArctic AB (publ) reported a quarterly eps of 3.33 SEK for 2023 Q1, up 604.55% from previous quarter.

Annual Eps Chart of BioArctic AB (publ) (2023 - 2015)

Historical Annual Eps of BioArctic AB (publ) (2023 - 2015)

Year Eps Eps Growth
2023 2.60 SEK 2100.0%
2022 -0.13 SEK 90.44%
2021 -1.36 SEK -74.36%
2020 -0.78 SEK -178.0%
2019 1.00 SEK -76.91%
2018 4.33 SEK 1868.18%
2017 0.22 SEK -66.15%
2016 0.65 SEK 1443.94%
2015 0.04 SEK 0.0%

Peer Eps Comparison of BioArctic AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK 572.727%
Ziccum AB (publ) -1.54 SEK 268.831%
Modus Therapeutics Holding AB (publ) -1.01 SEK 357.426%
Sprint Bioscience AB (publ) -0.01 SEK 41369.841%
Mendus AB (publ) -4.40 SEK 159.091%
Genovis AB (publ.) 0.94 SEK -176.596%
Intervacc AB (publ) -1.69 SEK 253.846%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK 1281.818%
Active Biotech AB (publ) -0.17 SEK 1629.412%
Magle Chemoswed Holding AB (publ) 1.13 SEK -130.088%
Bio-Works Technologies AB (publ) -1.57 SEK 265.605%
Aptahem AB (publ) -0.05 SEK 5483.023%
Vicore Pharma Holding AB (publ) -3.22 SEK 180.745%
Kancera AB (publ) -0.80 SEK 425.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 126.131%
Fluicell AB (publ) -0.24 SEK 1183.333%
Saniona AB (publ) -1.29 SEK 301.55%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK 1468.421%
Biovica International AB (publ) -2.14 SEK 221.495%
Spago Nanomedical AB (publ) -0.43 SEK 704.651%
AcouSort AB (publ) -1.29 SEK 301.55%
Xintela AB (publ) -0.13 SEK 2100.0%
Abliva AB (publ) -0.09 SEK 2976.106%
Egetis Therapeutics AB (publ) -1.27 SEK 304.724%
Karolinska Development AB (publ) 0.02 SEK -12900.0%
OncoZenge AB (publ) -1.36 SEK 291.176%
Amniotics AB (publ) -0.01 SEK 23736.364%
2cureX AB (publ) -1.85 SEK 240.541%
CombiGene AB (publ) -1.80 SEK 244.444%
Asarina Pharma AB (publ) -0.57 SEK 556.14%
Calliditas Therapeutics AB (publ) -8.69 SEK 129.919%
Camurus AB (publ) 7.78 SEK 66.581%
Corline Biomedical AB -0.08 SEK 3187.886%
IRLAB Therapeutics AB (publ) -3.43 SEK 175.802%
Isofol Medical AB (publ) -0.23 SEK 1230.435%
I-Tech AB 1.70 SEK -52.941%
Hansa Biopharma AB (publ) -15.83 SEK 116.425%
Cyxone AB (publ) -0.22 SEK 1281.818%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 231.313%
Biosergen AB -0.60 SEK 533.333%
Cantargia AB (publ) -1.65 SEK 257.576%
NextCell Pharma AB -1.03 SEK 352.427%
Xspray Pharma AB (publ) -6.76 SEK 138.462%
Elicera Therapeutics AB (publ) -0.83 SEK 413.253%
Nanologica AB (publ) -2.05 SEK 226.829%
SynAct Pharma AB -6.64 SEK 139.157%
Annexin Pharmaceuticals AB (publ) -0.26 SEK 1100.0%
Stayble Therapeutics AB (publ) -0.92 SEK 382.609%
LIDDS AB (publ) -0.63 SEK 512.698%
Lipum AB (publ) -4.45 SEK 158.427%
BioInvent International AB (publ) -5.02 SEK 151.793%
Alzinova AB (publ) -0.41 SEK 734.146%
Oncopeptides AB (publ) -1.96 SEK 232.653%
Pila Pharma AB (publ) -0.47 SEK 653.191%
Guard Therapeutics International AB (publ) -11.26 SEK 123.091%
Scandinavian ChemoTech AB (publ) -1.13 SEK 330.088%
Simris Alg AB (publ) -0.16 SEK 1725.0%
Diamyd Medical AB (publ) -1.60 SEK 262.5%
Xbrane Biopharma AB (publ) -1.27 SEK 304.724%
Ascelia Pharma AB (publ) -3.24 SEK 180.247%
Diagonal Bio AB (publ) -0.32 SEK 912.5%